Qu Biologics is a biopharmaceutical company located in Burnaby, BC, Canada. We are developing novel immunotherapies called Site Specific Immunomodulators (SSIs). Our goal is stimulate an innate immune response to reverse the chronic inflammation underlying many conditions such as Crohn’s disease and ulcerative colitis.
Our current clinical trial in Crohn’s disease has completed enrollment.
Learn more about Qu’s past clinical trials in:
Email us firstname.lastname@example.org for general inquiries. We appreciate your interest and will make every effort to reply to your message as soon as possible.